CORMEDIX INC. - COMMON STOCK

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

08 Apr 2025 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

02 Apr 2025 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

25 Mar 2025 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025

18 Mar 2025 08:30:00 By Nasdaq GlobeNewswire

CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities

21 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update

07 Jan 2025 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Added to Nasdaq Biotechnology Index

19 Dec 2024 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products

26 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

04 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

30 Oct 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces New Data at ASN Kidney Week 2024

24 Oct 2024 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

23 Oct 2024 08:30:00 By Nasdaq GlobeNewswire

CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator

08 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces New Commercial Agreement

19 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

13 Sep 2024 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces New Commercial Agreement

09 Sep 2024 10:52:30 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update

14 Aug 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024

07 Aug 2024 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Outpatient Availability of DefenCath

03 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

CorMedix Inc. Receives FDA Feedback on Potential Label Expansion

18 Jun 2024 08:00:00 By Nasdaq GlobeNewswire